Rnjak, D., Batarilo Hađar, M., Pelicarić, D., Vukić, T., Janković Makek, M., Samaržija, M. & Hećimović, A. (2023). Nintedanib treatment for bleomycin-induced lung injury - First report. Respiratory Medicine Case Reports, 46.. doi: 10.1016/j.rmcr.2023.101921
Rnjak, Dina, et al. "Nintedanib treatment for bleomycin-induced lung injury - First report." Respiratory Medicine Case Reports, vol. 46, 2023. https://doi.org/10.1016/j.rmcr.2023.101921
Rnjak, Dina, Martina Batarilo Hađar, Dubravka Pelicarić, Tea Vukić, Mateja Janković Makek, Miroslav Samaržija and Ana Hećimović. "Nintedanib treatment for bleomycin-induced lung injury - First report." Respiratory Medicine Case Reports 46 (2023). https://doi.org/10.1016/j.rmcr.2023.101921
Rnjak, D., et al. (2023) 'Nintedanib treatment for bleomycin-induced lung injury - First report', Respiratory Medicine Case Reports, 46. doi: 10.1016/j.rmcr.2023.101921
Rnjak D, Batarilo Hađar M, Pelicarić D, Vukić T, Janković Makek M, Samaržija M, and sur.. Nintedanib treatment for bleomycin-induced lung injury - First report. Respiratory Medicine Case Reports [Internet]. 2023 September 27 [cited 2024 December 07];46. doi: 10.1016/j.rmcr.2023.101921
D. Rnjak, et al., "Nintedanib treatment for bleomycin-induced lung injury - First report", Respiratory Medicine Case Reports, vol. 46, September 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:407335. [Accessed: 07 December 2024]